Jazz Pharmaceuti (JAZZ)
$138.51
0.55 (0.40%)
JAZZ Stock Quote Delayed 30 Minutes
5 Hot Marijuana Stocks as Beer Companies Shop for an Acquisition
After taking a pause in its uptrend, marijuana stocks could get a lift again as Molson Coors shops for companies in this sector. Though the sector has yet to prove it is profitable, a buyout will lift nearly all marijuana stocks.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$136.05
Market Cap
8.38B
PE Ratio
16.32
EPS
8.4869
Volume (Avg. Vol.)
995,298
Day's Range
$135.25 - $138.20
52-Week Range
$99.06 - $148.06
Dividend & Yield
N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharmaceuti News
3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement
Marijuana ETFs may still be few and far between, but these three are more than enough to get regular investors safely into the game.
Philip Morris International Inc. Stock Went Up in Smoke — Go Long
PM stock has a proven track record of strong management. The demise of its industry has been erroneously called too many times. This too shall pass.
Why GW Pharmaceuticals Stock Is Soaring Today
GW Pharmaceuticals (GWPH) stock was up today on news that the U.S. Food and Drug Administration may approve its drug derived from cannabis.
GW Pharmaceuticals PLC – ADR (GWPH) Garners EMA Cannabidiol Approval
GW Pharmaceuticals (GWPH) has received review approval for the treatment of Epidiolex (cannabidiol), used to treat seizure patients with LGS and Dravet syndrome.
GW Pharmaceuticals PLC- ADR Stock Is Set for a STRONG Comeback
GWPH stock has hit a few road blocks, but it should be able to overcome them in the years ahead. Here's what investors need to know about GW Pharmaceuticals.
Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally
Marijuana stock investing is fraught with risks, after the big run-up recently. Scrutinize the earnings potential for these companies first.
It’s Time for the Feds to Clarify Their Definition of Marijuana
Stand on whichever side of the marijuana legalization fence you want to, but let's at least hammer out some fact-based decisions.
Get Long GW Pharmaceuticals PLC- ADR for Free
Pharmaceutical stocks tend to be wild. I use the uncertainty to create income out of thin air in GWPH stock.
GW Pharmaceuticals PLC- ADR (GWPH) Stock Is High-Risk, High Reward
GW Pharmaceuticals is all about risk. If it can survive the path to Epidiolex success, GWPH stock longs with iron stomachs will be rewarded.
Get Long GW Pharmaceuticals PLC- ADR (GWPH) Stock for Free
The pharma sector is more volatile than normal due to political influence. I will capitalize on that by selling puts in GWPH stock for income.
5 Pharmaceuticals Stocks to Buy Now
The grades of 5 Pharmaceuticals stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
GW Pharmaceuticals PLC- ADR (GWPH) Stock Is Just Getting Started
GW Pharmaceuticals took a big leap forward today, but these next few years are when GWPH stock will really start to shine.
GW Pharmaceuticals (GWPH) Stock Landed a 1-2 Ballot Punch
GW Pharmaceuticals could benefit from 2016's vote to more lenient cannabis laws, but the real victory for GWPH stock was Clinton's loss.
